55 results
Page 2 of 3
8-K
EX-1.1
oo2b21z743m97jm2r5mz
8 Jan 20
Entry into a Material Definitive Agreement
5:12pm
8-K
EX-99.2
3nrng9vjykf g3mcimn
8 Jan 20
Entry into a Material Definitive Agreement
5:12pm
8-K
EX-99.1
augc7869zee183y bxj3
6 Jan 20
Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock
4:52pm
8-K
EX-99.1
2tbtgbwzfe0 akf
8 Jul 19
Intra-Cellular Therapies Announces PositiveTop-line Results from a Phase 3 Trial of Lumateperone in Patients with Bipolar Depression
7:10am
8-K
EX-99.1
051dau
28 Sep 15
Intra-Cellular Therapies Announces Closing of $345 Million Public Offering Including
12:00am
8-K
EX-99.2
e8qt5j5yjbuidzc744l
6 Mar 15
Entry into a Material Definitive Agreement
12:00am
8-K
EX-1.1
tzf858 0bcdv
6 Mar 15
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
l8a08a6wjgwi8v evsc
4 Mar 15
Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock
12:00am
424B3
74leqtw
4 Apr 14
Prospectus supplement
12:00am
8-K
EX-99.2
9x8bx0zhnz4fm
5 Feb 14
Other Events
12:00am
8-K
EX-99.1
dtmm2vrp8n
5 Feb 14
Other Events
12:00am
424B3
t39bb6
5 Feb 14
Prospectus supplement
12:00am